Search Results

You are looking at 1 - 10 of 465 items for :

  • "psychotherapy" x
  • Refine by Access: All Content x
Clear All
Orvosi Hetilap
Authors: Barbara Papp and Bernadette Péley

Pintér, G.: Research. In: Szőnyi, G., Füredi, J. (eds.): Textbook of psychotherapy. [Kutatás. In: Szőnyi, G., Füredi, J. (szerk.): A pszichoterápia tankönyve.] Medicina Könyvkiadó, Budapest, 2000. [Hungarian

Restricted access

, A. , & Fonagy , P. ( 2005 ). Psychotherapy for borderline personality . Oxford : Oxford University Press. Becker , B. , Bell , M. , & Billington , R. ( 1987 ). Object

Open access

) Disorganized Attachment, Models of Borderline States and Evolutionary Psychotherapy. In Gilbert , P., Bailey , K. G. (eds) Genes On the Couch. Explorations in Evolutionary Psychotherapy . 232–256. Routledge, London

Restricted access

these medicines as dangerous and lacking in observable medical benefits ( Barnett, Siu, & Pope, 2018 ; Nutt, King, & Nichols, 2013 ; Sessa, 2017 ). On the other hand, MDMA is the pharmacological component of MDMA-assisted psychotherapy, an FDA

Open access

adjuncts to psychotherapy ( Mithoefer et al., 2018; Rodriguez et al., 2016; Wilkinson et al., 2017 ). However, very little of this research has focused on people of color, and there are no accounts that represent the experience of Black women. The purpose

Open access

Narrative and Psychotherapy (pp. 283–295). London: Sage Publications. Bruner, J. (1990). Acts of meaning . Cambridge, MA: Harvard University Press. Bruner, J. (2005). Valóságosak elmék, lehetséges

Restricted access

. Practical oncopsychology. [Onkopszichológia a gyakorlatban.] 2006 Szőnyi, G.: Common questions of psychotherapies

Restricted access

Erikson, E. H. (1968) Identity: Youth and Crisis . Norton, New York Fava, G. A. (1999) Well-being therapy. Psychotherapy and Psychosomatics, 68, 171–178. Fava, G. A

Restricted access

Beck, A. T. (1997) The past and future of cognitive therapy. Journal of Psychotherapy Practice and Research, 6, 276–284. Butler, A., Chapman, J., Forman, E., Beck, A

Restricted access

burden ( WHO, 2017 ). Lifetime prevalence in the United States is approximately 20% ( Hasin et al., 2018 ). Over 500 clinical trials and 70 meta-analyses of relevant medications and psychotherapies suggest moderate but imperfect rates of treatment

Open access